BLINCYTO (blinatumomab) is a bispecific CD19-directed CD3 T-cell engager that binds to CD19 (expressed on cells of B-lineage origin) and CD3 (expressed on T cells). BLINCYTO is produced in Chinese hamster ovary cells. It consists of 504 amino acids and has a molecular weight of approximately 54 kilodaltons for intravenous administration. Each single-dose pharmaceutical vials of BLINCYTO contains 35 mcg blinatumomab, citric acid monohydrate (3.35 mg), lysine hydrochloride (23.23 mg), polysorbate 80 (0.64 mg), trehalose dihydrate (95.5 mg), and sodium hydroxide to adjust pH to 7.0.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Treatment of Cancer
Store in a refrigerator (2 - 8°C). Do not freeze.℃
Shelcal - HD Tablet helps to treat Calcium deficiency that leads to weak bones as the body will start using calcium from the bone. The right amount of Vitamin D, Calcium, and Phosphorus is important for building and keeping strong bones. Shelcal - HD Tablet helps to treat Calcium deficiency that leads to weak bones as the body will start using calcium from the bone. The right amount of Vitamin D, Calcium, and Phosphorus is important for building and keeping strong bones.
0.0
0 Reviews